I use Advair Diskus twice daily for my asthma.

I recently purchased a three-month supply, for which I paid $410. I have insurance. That is a lot of money for someone whose primary source of income is Social Security.

A couple days later, out of curiosity, I called Canada Pharmacy to get their price. It would be only $299 — quite a difference. I could get the generic for only $91.

Here, in the U.S., I can’t get the generic because some brand name companies are entering into agreement with generic drug companies that pay the generic company to delay bringing a competing product to the market. I learned this from an edition of AARP bulletin.

We need to remind our legislators of this practice and tell them that they can do something about it.

This is totally unfair.

Don Holmes

Buchanan